{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:52:11Z","timestamp":1790254331418,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.crohns.2012.01.014","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T16:32:49Z","timestamp":1330101169000},"page":"713-716","source":"Crossref","is-referenced-by-count":17,"title":["Anti-TNF therapy induced immune neutropenia in Crohns disease- report of 2 cases and review of literature"],"prefix":"10.1093","volume":"6","author":[{"given":"Shaji","family":"Sebastian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Houston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina Mary","family":"Diggory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"issue":"3","key":"10.1016\/j.crohns.2012.01.014_bb0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.crohns.2009.12.001","article-title":"The Austrian evidence based consensus on the safe use of Infliximab in inflammatory bowel disease","volume":"4","author":"Meihsler","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.crohns.2012.01.014_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","article-title":"European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"3","author":"Rahier","year":"2009","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.crohns.2012.01.014_bb0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/11538330-000000000-00000","article-title":"Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase","volume":"339","author":"Giezen","year":"2010","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.crohns.2012.01.014_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management","volume":"4","author":"Dignass","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.crohns.2012.01.014_bb0025","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1136\/ard.2006.056176","article-title":"Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis","volume":"65","author":"Rajakulendran","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.crohns.2012.01.014_bb0030","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10875-008-9214-3","article-title":"Impact of three anti-TNF alpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondyloarthropathy patients","volume":"28","author":"Bacquet-Deschryver","year":"2008","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.crohns.2012.01.014_bb0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0016-5085(03)00701-7","article-title":"Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study","volume":"125","author":"Vermiere","year":"2003","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.crohns.2012.01.014_bb0040","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/01.MIB.0000186408.07769.78","article-title":"Infliximab treatment does not induce organ-specific or nonorgan-specific autoantibodies other than antinuclear and anti-double-stranded DNA autoantibodies in Crohn's disease","volume":"11","author":"Nancey","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2012.01.014_bb0045","first-page":"495863","article-title":"Drug-induced hematologic syndromes","volume":"7","author":"Mintzer","year":"2009","journal-title":"Adv Hematol"},{"issue":"30","key":"10.1016\/j.crohns.2012.01.014_bb0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jbspin.2008.09.017","article-title":"Adalimumab induced neutropenia in a patient with rheumatoid arthritis","volume":"76","author":"Ottaviani","year":"2009","journal-title":"Joint Bone Spine"},{"issue":"20","key":"10.1016\/j.crohns.2012.01.014_bb0055","first-page":"247","article-title":"Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthopathy","volume":"23","author":"Favalli","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.crohns.2012.01.014_bb0060","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s10067-006-0415-y","article-title":"Antitumour necrosis factor-induced neutropenia: a case report with double positive challenges","volume":"26","author":"Montane","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.crohns.2012.01.014_bb0065","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1034\/j.1600-0609.2003.00115.x","article-title":"Aplastic anemia following administration of a tumour necrosis factor-alpha inhibitor","volume":"71","author":"Kuruvilla","year":"2003","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.crohns.2012.01.014_bb0070","doi-asserted-by":"crossref","first-page":"W-W63","DOI":"10.7326\/0003-4819-139-3-200308050-00021-w4","article-title":"Severe neutropenia and thrombocytopenia associated with infliximab","volume":"139","author":"Vidal","year":"2003","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.crohns.2012.01.014_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2257.2007.00899.x","article-title":"Severe antibody mediated agranulocytosis","volume":"30","author":"Johnsen","year":"2008","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"10.1016\/j.crohns.2012.01.014_bb0080","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s10067-006-0229-y","article-title":"A case report of tumor necrosis factor- alpha antibody induced thromobocytopenia associated with emerging IgM anticardiolipin antibody in patients with scleroderma overlap\/rheumatoid arthritis","volume":"26","author":"Hamaguchi","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.crohns.2012.01.014_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000187637","article-title":"Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody Infliximab for refractory fistulizing Crohns disease","volume":"78","author":"de Rossi","year":"2008","journal-title":"Digestion"},{"key":"10.1016\/j.crohns.2012.01.014_bb0090","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V95.10.3219","article-title":"Chronic neutropenia mediated by fas ligand","volume":"95","author":"Liu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.crohns.2012.01.014_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00296-006-0187-3","article-title":"Reversible T-large granular lymphocyte expansion and neutropenia associated with adalimumab therapy","volume":"27","author":"Theodoridou","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.crohns.2012.01.014_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0889-857X(05)70211-8","article-title":"Tuour necrosis factor alpha blockade in the treatment of rheumatoid arthritis","volume":"27","author":"Keystone","year":"2001","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994612000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994612000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/6\/6\/713\/1084273\/6-6-713.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T10:36:58Z","timestamp":1713609418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2012.01.014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1873994612000207"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2012.01.014","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}